公开(公告)号：EP1608738A2

公开(公告)日：2005-12-28

申请号：EP04757690.5

申请日：2004-03-13

申请人： GERON CORPORATION

发明人： STANTON, Lawrence, W. ,  BRANDENBERGER, Ralph ,  BRUNETTE, Elisa ,  GOLD, Joseph, D. ,  IRVING, John, M. ,  MANDALAM, Ramkumar ,  MOK, Michael ,  POWELL, Sandra, E. ,  SHELTON, Dawne

IPC分类号： C12N5/00 ,  C12N5/06 ,  C12N5/08 ,  C12N15/00 ,  C12N15/09 ,  C12N15/63 ,  C12N15/70 ,  C12N15/74 ,  C07H21/02 ,  C07H21/04

CPC分类号： C12Q1/6876 ,  C12Q1/68 ,  C12Q1/6886 ,  C12Q2600/158

摘要： Genes that are up- or down-regulated during differentiation provide important leverage by which to characterize and manipulate early-stage pluripotent stem cells. Over 35,000 unique transcripts have been amplified and sequenced from undifferentiated human embryonic stem cells, and three types of differentiated progeny. Statistical analysis of the assembled transcripts identified genes that alter expression levels as differentiation proceeds. The expression profile provides a marker system that has been used to identify particular culture components for maintaining the undifferentiated phenotype. The gene products can also be used to promote differentiation; to assess other relatively undifferentiated cells (such as cancer cells); to control gene expression; or to separate cells having desirable characteristics. Manipulation of particular genes can be used to forestall or focus the differentiation process, en route to producing a specialized homogenous cell population suitable for human therapy.